
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.
They have done so much to de-risk their balance sheet and to change the structure of the products that they sell, to be more profitable and less capital markets related. Have built a very strong balance sheet and one of the best capital bases in the industry. Have undertaken some tremendous growth initiatives in Asia as well as the US. Recently made a distribution deal in Asia. Have become very long term in focus and the ROE is improving, which he expects is going to be over 10% going forward. Yield of 2.8%.
Sees 16% in earnings growth over the next couple of years, along with 14% dividend growth. They just combined with an Asian bank to get exclusivity on insurance products. Have stumbled over the last couple of years. EPS has been missing on the core earnings, but they are on track for their 2016 plan. When interest rates go higher, this will be a beneficiary.
Low interest rates creates a real challenge for lifecos. This one has done a good job of transitioning from an insurance company to being more of a wealth management name. Their US wealth management is about 40% of their overall revenue. The real opportunity for them is in Asia and they have positioned themselves well to really compete in that space. He is looking at this name. 2.8% dividend yield.
In lifecos, this would be his favourite. It has the best growth including Asian growth. The catalyst will be that their spreads will widen as rates go up. They are not as sensitive to others as they hedged out in 2008-2009 when rates hit. Starting to give dividend increases which will become more regular. This will give you 8%-10% returns instead of the 5% that we have had.
You think of most financials as benefiting from high interest rates, as they are able to capture a higher spread when rates are rising. People like this one as they have a substantial business in the US. They are also able to grow in Asia. As long as you have lower and declining interest rates, that is a headwind for them.
This would be a reasonable entry point. If you are of the view, which he is, that things are getting better in the economy, one of the things that do well in a rising economy is financials. In lifecos, your liabilities are discounted at a higher rate. They also do well in the asset management side of the business. Growth gives them opportunities for acquisition as well as expansion of their businesses. This is very big in Asia which continues to be a bright spot for them. Good name.